Jennifer Cook

Jennifer E.
Cook currently works at Jazz Pharmaceuticals Plc, as Independent Director from 2020, Denali Therapeutics, Inc., as Independent Director from 2018, BridgeBio Pharma LLC, as Director, Ambys Medicines, Inc., as Director from 2020, Gyroscope Therapeutics Ltd., as Director from 2020, BridgeBio Pharma, Inc., as Independent Non-Executive Director from 2019, and Jennifer Cook Consulting, as Principal.
Ms. Cook also formerly worked at GRAIL, Inc., as Chief Executive Officer & Director from 2018 to 2019, Gyroscope Therapeutics Holdings Plc, as Non-Executive Director from 2020 to 2022, Genentech, Inc., as Senior Vice President-Immunology & Ophthalmology from 2011 to 2013, Roche Pharmaceuticals, Inc., as Senior VP & Global Head-Clinical Operations in 2017, and Prizm Pharmaceuticals, Inc., as Principal.
Ms. Cook received her undergraduate degree and graduate degree from Stanford University and Masters Business Admin degree from Haas School of Business.